Real-time enrollment status for this i cannot determine the primary medical condition from the provided information. the study title mentions "regeneron aa multicenter (dupilumab)" but "aa" is too ambiguous, and the conditions field only lists drug names rather than medical conditions. the brief summary field appears to be incomplete (showing only a localhost url). without additional context about what condition dupilumab is being tested for in this specific trial, i cannot provide the patient-facing medical condition. clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:47 AM UTC
| NCT Number | NCT05551793 |
| Recruiting Status | Recruiting |
| Condition | I cannot determine the primary medical condition from the provided information. The study title mentions "Regeneron AA Multicenter (Dupilumab)" but "AA" is too ambiguous, and the conditions field only lists drug names rather than medical conditions. The brief summary field appears to be incomplete (showing only a localhost URL). Without additional context about what condition dupilumab is being tested for in this specific trial, I cannot provide the patient-facing medical condition. |
| Phase | Clinical Trial |
| Target Enrollment | 68 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Emma Guttman |
| Last Updated on CT.gov | July 29, 2025 (Jul 29, 2025) |
As of March 2, 2026: Clinical trial NCT05551793 is currently recruiting participants. This clinical trial study for i cannot determine the primary medical condition from the provided information. the study title mentions "regeneron aa multicenter (dupilumab)" but "aa" is too ambiguous, and the conditions field only lists drug names rather than medical conditions. the brief summary field appears to be incomplete (showing only a localhost url). without additional context about what condition dupilumab is being tested for in this specific trial, i cannot provide the patient-facing medical condition. is actively seeking new participants at 3 locations across the United States. The study is sponsored by Emma Guttman. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05551793 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05551793 was last updated Jul 29, 2025 (July 29, 2025). HelloStudys verifies this status automatically.